ABSTRACT
INTRODUCTION Regulatory inspections are conducted before a new drug or device can be approved, to verify production method and technology changes, and periodically verify every two or three years that GxP practices are being maintained. Inspections are used to determine if processes are adequately validated with documentary evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality characteristics (1).
